Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Fortrea to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Analyst Recommendations This is a […]
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare Fortrea to similar companies based on the strength of its earnings, institutional ownership, dividends, profitability, valuation, analyst recommendations and risk. Insider & Institutional Ownership 47.5% of shares […]
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it compare to its competitors? We will compare Fortrea to similar businesses based on the strength of its earnings, dividends, institutional ownership, risk, valuation, profitability and analyst recommendations. Profitability This table compares Fortrea and its […]
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Fortrea to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a […]
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its rivals? We will compare Fortrea to similar businesses based on the strength of its dividends, analyst recommendations, risk, institutional ownership, profitability, valuation and earnings. Analyst Recommendations This is a […]